12 / June / 2024 COVID-19: High levels of immunity hinder clinical trials Clinical trials conducted in 2021 and 2022 were unable to find a dosage of the SARS-CoV-2 virus capable of infecting volunteers in challenge studies Por Editorial staff
09 / February / 2024 New drug offers hope for treating COVID-19 Cancer drug tested on animals has anti-inflammatory and antiviral effect against SARS-CoV-2 Por Editorial staff
